United States· US:68727-800_0269ad44-e351-4411-8866-d8d53e28fb74
DEFITELIO
A defibrotide product containing defibrotide sodium, registered in United States by Jazz Pharmaceuticals, Inc.. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Defibrotide is registered in 15 of 19 countries.
Countries holding a registration under ATC B01AX01 (defibrotide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Defibrotide · ATC B01AX01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEFIBROTIDE SODIUM
- Manufacturer
- Jazz Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- B01AX01
- ATC class
- Defibrotide
- Defined daily dose
- 1.75 g, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1168727800012.5 mL in 1 VIAL (68727-800-01)
- ndc11687278000225 mL in 1 CARTON (68727-800-02)
- ndc1168727-800-01
- ndc1168727-800-02
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
136 interactions on record for defibrotide.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Defibrotide · interactions on record
136 records
- 71 severe
- 65 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AX01
Defibrotide, as other registers publish it.
- DenmarkDefitelioGentium SpA
- PolandDefitelioGentium S.r.l.
- IcelandDefitelioGentium S.r.l.
- FinlandDefitelioGentium S.r.l.
- NorwayDefitelioGentium S.r.l.
- CzechiaDEFITELIOGentium S.r.l., Villla Guardia, Como
- CanadaDEFITELIOJAZZ PHARMACEUTICALS IRELAND LIMITED
- United KingdomDefitelio 200mg/2.5ml concentrate for solution for infusion vialsJazz Pharmaceuticals UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b79b4975-6720-4021-b63d-4448ebd9fc6c GET /v1/drugs/b79b4975-6720-4021-b63d-4448ebd9fc6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "80",
"substance": "DEFIBROTIDE SODIUM",
"productndc": "68727-800",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA208114",
"marketing_category": "NDA"
}See everything about defibrotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.